ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Thomas Stegmann
Thomas tstegmann Stegmann, Professor, M.D., PhD
Background
Studies of Human Medicine: Final Examination - 1974
Doctor Thesis (Dissertation): summa cum laude - 1974
Price of Faculty (University of Heidelberg) - 1974
Hannover Medical School (MHH) 1976 - present; Prof.Borst, Prof.Pichlmayr, Prof.Tscherne
Licenses: General Surgery - 1982, Cardiothoracic & Vascular Surgery - 1983
Rudolf-Nissen-Memorial-Award - 1982; Appointment Professor of Surgery - 1989
Head of the Dept. of Thoracic & Cardiovascular Surgery, Fulda Medical Center (1984-2006)
Faculty Member MHH (since 1982); Founder, CardioVascular BioTherapeutics, Inc. (1998)
Member - New York Academy of Sciences (since 2007); Member - Ukrainian Academy of Med. Sciences
Founder, CMO, Board-Member, CardioVascular Therapeutics, Inc., Las Vegas, NV, USA
CEO, Phage Pharmaceuticals, Inc., USA
Other Interests
History
Sailing
Research
Angiogenic Therapy of Coronary Heart Disease
Angiogenesis, Myogenesis
Aortic Dissection
Heart & Lung Transplantation
Coronary Bypass Surgery
Angiogenic Growth Factors
Abdominal Aortic Aneurysm - Surgical Treatment
Surgery of the Aorta
Additional Educational Information
Hannover Medical School (MHH), Germany
Printer-friendlyPractice Areas
- Cardiac
- Thoracic
- Vascular
- Minimally Invasive
- Coronary disease
- Electrophysiology/arrhythmia
- Extracorporeal circulation
- Heart failure
- Pericardium
- Thoracic
- Diaphragm
- Mediastinum
- Pleura
- Congenital
- Aorta
- Critical Care
- Basic science